over 24 years of clinical trial experience
since the first HUMIRA trial in 1997.
Your doctor has prescribed HUMIRA for your moderate to severe chronic plaque psoriasis (Ps).
You probably have questions.
That’s not surprising. Starting on any new treatment plan can often feel overwhelming. The more you know about your prescribed treatment plan, the better prepared you’ll be to follow it.
Doctors have prescribed HUMIRA to help treat moderate to severe chronic plaque psoriasis since 2008.
About HUMIRA
More than 1.4 million patients worldwide
have been prescribed HUMIRA for an FDA-approved condition.*
*As of July 2020.
HUMIRA Complete Resources
The resources you need, when you need them.
HUMIRA Complete is more than just a support program. It’s our promise to be there for you with the information and resources you need to start and stay on track with HUMIRA.
Our dedicated Ambassadors* are the heart of HUMIRA Complete.
Your Ambassador is there to get to know you and your treatment needs to provide you with personalized, 1-to-1 help every step of the way.
Prefer to meet virtually? Ask your Ambassador if virtual visits are available.
You can also ask your Ambassador for help connecting you with resources, such as:
Your Ambassador is always here to help you.
If you have questions or need help accessing the resources above, reach out to your Ambassador or call 1.800.4HUMIRA (1.800.448.6472).
*Nurse Ambassadors are provided by AbbVie and do not work under the direction of your health care professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.
Eligibility: Available to patients with commercial insurance coverage for HUMIRA® (adalimumab) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit HUMIRASavingsCard.com or call 1.800.4HUMIRA for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy
Understanding Plaque Psoriasis
Understanding a complex condition.
The more you know about moderate to severe chronic plaque psoriasis (Ps) and what to expect, the easier it may be to understand your condition. This can also help you explain your experience to others.
Chronic
A chronic, inflammatory disease
Since Ps is chronic, the inflammation that contributes to Ps symptoms will likely be persistent. So once you have Ps, you will likely always have it since there is no known cure.
ANYWHERE
Where it strikes
Ps can appear on any part of your body. It is typically found on the elbows, knees, and sometimes on fingernails.
Causes
A combination of causes
The exact cause of Ps is unknown, but it is believed to be caused by a combination of immune, genetic, and environmental factors.
Who is at Risk for Plaque Psoriasis
A combination of factors.
Anyone can get moderate to severe chronic plaque psoriasis (Ps), but there are risk factors that may increase your chances. Talk to your doctor to learn more about possible risk factors.
How Your Immune System Triggers Inflammation
The immune system/inflammation connection.
Normally the immune system protects your body by attacking disease-causing germs, including bacteria and viruses. But with plaque psoriasis (Ps), the immune system becomes overactive.
Immune System Overreacts
The overactivity of the immune system speeds up the growth cycle of skin cells.
Skin cells fall off quicker
This sets off a chain reaction causing activation of other cells and proteins involved in inflammatory response, such as tumor necrosis factor-alpha (TNF-alpha). This process causes skin cells to mature and die faster than normal skin cells.
Inflammation
As a result, skin cells build up on the surface of the skin and form thick, red, flaky skin patches known as "plaques."
Plaque Psoriasis Symptoms
Know the signs.
The signs and symptoms of moderate to severe chronic plaque psoriasis may include:
How HUMIRA Works
How HUMIRA works from the inside out.
The exact cause is unknown, but plaque psoriasis has been linked to the immune system and an excess of several proteins in the body, including one called tumor necrosis factor-alpha (TNF-alpha).
Too much TNF-alpha may lead to faster growth of skin cells, which can lead to the plaques—red, flaky patches—you see on your skin.
HUMIRA works by targeting TNF-alpha and blocking it in order to help reduce inflammation that may contribute to plaque psoriasis symptoms like plaques.
Who is HUMIRA for?
HUMIRA is a prescription medicine used to treat adults with moderate to severe chronic plaque psoriasis who are ready for systemic therapy or phototherapy, and are under the care of a doctor who will decide if other systemic therapies are less appropriate.
How HUMIRA Helps Treat Moderate to Severe Chronic Plaque Psoriasis
Proven to help adults with moderate to severe chronic plaque psoriasis have clearer skin.
In clinical trials, most patients taking HUMIRA were clear or almost clear at 4 months.
Many saw:
75% and even 90%
skin clearance in just 4 months.*
Of people who achieved 75% clearer skin, most maintained it a full year after starting treatment.*
*Individual results may vary.
You can see more before and after HUMIRA pictures by clicking through the gallery below.
Computerized illustration of 75% skin clearance at 4 months. Individual results may vary.
Computerized illustration of 75% skin clearance at 4 months. Individual results may vary.
75% skin clearance in just 4 months in HUMIRA patients from clinical trials. Individual results may vary.
90% skin clearance in just 4 months in HUMIRA patients from clinical trials. Individual results may vary.
90% skin clearance in just 4 months in HUMIRA patients from clinical trials. Individual results may vary.
Computerized illustration of improvement of moderate to severe fingernail psoriasis at week 26. Individual results may vary.
In a clinical study, many people with moderate to severe chronic plaque psoriasis with moderate to severe fingernail psoriasis taking HUMIRA saw significant improvement at 26 weeks.
Additional Safety Information
Before making a decision, get the facts.
Discuss Important Safety Information for HUMIRA with your doctor.
Before you and your doctor make a decision about treatment, you should discuss the Important Safety Information for HUMIRA. Talk about any concerns you may have. Working together, you and your doctor can find a treatment that is right for you.
What is the most important information I should know about HUMIRA?
You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a tumor necrosis factor (TNF) blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay.
- Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB.
- Cancer. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal.
Learn about the most common side effects of HUMIRA.
Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.
It is possible to experience adverse events or side effects from HUMIRA. If you do experience any side effects, call your doctor right away. These are not all of the possible side effects associated with HUMIRA. Click here to see additional Important Safety Information.